| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-08 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-07 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-07 |
| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |